QDTI - quantum powered biomarker detection
QDTI's all-magnetic approach solves the key limitations with current state-of-the-art optical detection-based technologies for biomarkers, including: long time to results; cumbersome, extensive sample washing; and, significant environmental, resource and financial costs. The QDTI imaging platform – using magnetic tags – enables an inexpensive, more reliable, more flexible way to achieve a high-performance biomarker detection. The QDTI magnetic detection approach improves identification of multiple types of biomarkers – proteins, nucleic acids, cells – and will impact all phases of biomedical research and patient care. The QDTI system uses quantum mechanics to enable ultrasensitive detection of biomarkers. The QDTI diagnostic protocol requires only 5µL of sample to perform the assay – a critical benefit when sample availability is limited. The QDTI magnetic-based assay requires minimal sample processing. The QDTI approach requires 90% less hands-on time. QDTI is building a flexible system from the start.
This company is:
.jpg&w=3840&q=75)
Verified
Products
Meet the QDTI Team, experts in the commercial application of quantum technology and biomarker diagnostics.
Verified
NIST Awards a Phase II Grant to Support QDTI’s Development of NV Imaging to Support Single Magnetic Nanoparticle Development
Following a successful Phase I SBIR research program, the National Institute of Standards and Technology (NIST), a key federal science and technology agency, has awarded QDTI a Phase II SBIR contract to continue development of a platform for high-speed single magnetic nanoparticle analysis using the company’s quantum NV diamond sensing technology. Magnetic nanoparticles and beads are a key component of many biomedical diagnostics products, but the lack of a technology allowing individual magnetic particles to be tested quickly has hindered quality control and further technical development. QDTI’s technology allows the magnetic properties of thousands of magnetic particles to be tested in parallel.
Verified
DARPA Continues Its Support for Development of QDTI’s Novel NV Diamond Imaging Technology
The Defense Advanced Research Projects Agency (DARPA) has exercised its option to continue its support to QDTI for development of the company’s Nitrogen Vacancy (NV) diamond imaging technology. DARPA has been a major supporter of the development of NV technology through its QuASAR quantum sensing program. DARPA’s decision will increase its total support to QDTI for development of the technology through the agency’s SBIR program. QDTI is using the NV imaging technology to develop a new class of ultrasensitive biomedical diagnostics suitable for a wide range of protein, cellular and nucleic acid targets.
View all products
Keywords
Industries
Where is Quantum Diamond Technologies located?
The company Quantum Diamond Technologies is located in Somerville, Massachusetts, United States. It's worth noting that the company may has more corporate locations
How many employees does Quantum Diamond Technologies approximately have?
As of the latest available information Quantum Diamond Technologies has around 11-50 employees worldwide.
When was Quantum Diamond Technologies founded?
Quantum Diamond Technologies was founded in 2015
In which industries does Quantum Diamond Technologies mainly work?
The company Quantum Diamond Technologies has it's main focus in the industries of Biotechnology, Science and Engineering
Quantum Design, Inc.
United States
101-250 Employees
1982
MagArray
United States
11-50 Employees
2005
QDI systems
Netherlands
1-10 Employees
2019
Invitrometrix
United States
1-10 Employees
2016
Qcdx LLC
United States
1-10 Employees
2016
Depixus
France
11-50 Employees
2012
Core Quantum Technologies
United States
1-10 Employees
2012
LifeOS Genomics
Taiwan
11-50 Employees
2015
Topics which have been searched by others and may be interesting for you:
